USP39 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.66533453693773E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.25455201782643E-14 |
Normal-vs-Stage2 |
1.72909997431248E-09 |
Normal-vs-Stage3 |
2.0220491947498E-12 |
Normal-vs-Stage4 |
2.08520000000156E-06 |
Stage1-vs-Stage2 |
7.801400E-01 |
Stage1-vs-Stage3 |
3.474600E-01 |
Stage1-vs-Stage4 |
2.010400E-01 |
Stage2-vs-Stage3 |
6.943600E-01 |
Stage2-vs-Stage4 |
2.052000E-01 |
Stage3-vs-Stage4 |
7.024500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62536650805123E-12 |
Normal-vs-AfricanAmerican |
9.94810001042623E-09 |
Normal-vs-Asian |
8.916400E-01 |
Caucasian-vs-AfricanAmerican |
5.400800E-01 |
Caucasian-vs-Asian |
2.223700E-03 |
AfricanAmerican-vs-Asian |
6.176600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.12052597703405E-14 |
Normal-vs-Female |
3.31079608173468E-12 |
Male-vs-Female |
6.007800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.58069999999233E-05 |
Normal-vs-Age(41-60Yrs) |
4.01467747934703E-12 |
Normal-vs-Age(61-80Yrs) |
1.70519154352178E-12 |
Normal-vs-Age(81-100Yrs) |
5.66780000044176E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.721200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.042800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.864800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.694600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.568800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.413200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.459460E-03 |
Normal-vs-Grade 2 |
1.99840144432528E-15 |
Normal-vs-Grade 3 |
1.63102864547682E-12 |
Normal-vs-Grade 4 |
6.39559999999761E-05 |
Grade 1-vs-Grade 2 |
7.682000E-01 |
Grade 1-vs-Grade 3 |
5.532000E-01 |
Grade 1-vs-Grade 4 |
6.161200E-01 |
Grade 2-vs-Grade 3 |
3.131200E-01 |
Grade 2-vs-Grade 4 |
1.112350E-01 |
Grade 3-vs-Grade 4 |
3.580300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.10387263166467E-13 |
Normal-vs-ccB subtype |
4.62220000052582E-08 |
ccA subtype-vs-ccB subtype |
7.149600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.39286409867645E-12 |
Normal-vs-N1 |
1.706620E-01 |
N0-vs-N1 |
4.127600E-02 |
|
|